Unequivocally positive results were also found when only one acute-phase protein, CRP, was included in the meta-analysis: GLP1RA significantly decreased serum CRP in patients with diabetes and different co-morbidities, such as: coronary artery disease, obesity, hypertension, non-alcoholic fatty liver disease and psoriasis [130]. The gene discussed is CRP; the disease is obesity disorder.